https://www.aafp.org/pubs/afp/issues/2019/0515/p643.html
Glycopyrrolate (Lonhala Magnair) for Treatment of Chronic Obstructive Pulmonary Disease | AAFP
Glycopyrrolate is a safe alternative to long-acting muscarinic antagonists delivered by metered-dose inhaler for patients with moderate to severe COPD.
pulmonary diseaseglycopyrrolatetreatment